Michael Megaly to Myocardial Infarction
This is a "connection" page, showing publications Michael Megaly has written about Myocardial Infarction.
Connection Strength
8.222
-
Early vs. delayed mechanical circulatory support in patients with acute myocardial infarction and cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2024 May 28; 13(5):390-397.
Score: 0.745
-
Use of a Multidisciplinary Shock Team and Inhospital Mortality in Patients With Cardiogenic Shock. Am J Cardiol. 2023 11 01; 206:200-201.
Score: 0.709
-
Meta-Analysis on Invasive Versus Conservative Strategy in Patients Older Than Seventy Years With Non-ST Elevation Myocardial Infarction. Am J Cardiol. 2023 01 01; 186:66-70.
Score: 0.668
-
Utilization of Non-Drug-Eluting Devices for Inpatient Percutaneous Coronary Intervention in the United States. Am J Cardiol. 2023 01 01; 186:209-215.
Score: 0.668
-
Extraplaque versus intraplaque tracking in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2022 11; 100(6):1021-1029.
Score: 0.663
-
Trends and Outcomes of Myocardial Infarction in Patients With Previous Coronary Artery Bypass Surgery. Am J Cardiol. 2022 09 15; 179:11-17.
Score: 0.655
-
Comparative Analysis of Patient Characteristics in Cardiogenic Shock Studies: Differences Between Trials and Registries. JACC Cardiovasc Interv. 2022 02 14; 15(3):297-304.
Score: 0.636
-
Outcomes of successful vs. failed contemporary chronic total occlusion percutaneous coronary intervention. Cardiovasc Interv Ther. 2022 Jul; 37(3):483-489.
Score: 0.623
-
Diabetic Patients Who Present With ST-Elevation Myocardial Infarction. Cardiovasc Revasc Med. 2022 05; 38:89-93.
Score: 0.613
-
Outcomes With Drug-Coated Balloons vs. Drug-Eluting Stents in Small-Vessel Coronary Artery Disease. Cardiovasc Revasc Med. 2022 02; 35:76-82.
Score: 0.597
-
Systematic review and meta-analysis of short-term outcomes with drug-coated balloons vs. stenting in acute myocardial infarction. Cardiovasc Interv Ther. 2021 Oct; 36(4):481-489.
Score: 0.579
-
Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Previous Coronary Artery Bypass Graft Surgery. Am J Cardiol. 2023 10 15; 205:40-49.
Score: 0.176
-
Outcomes and Institutional Variation in Arterial Access Among Patients With AMI and Cardiogenic Shock Undergoing PCI. JACC Cardiovasc Interv. 2023 06 26; 16(12):1517-1528.
Score: 0.175
-
The impact of moderate aortic stenosis in acute myocardial infarction: A multicenter retrospective study. Catheter Cardiovasc Interv. 2023 07; 102(1):159-165.
Score: 0.173
-
Meta-Analysis on Transcarotid Versus Transfemoral and Other Alternate Accesses for Transcatheter Aortic Valve Implantation. Am J Cardiol. 2023 04 01; 192:196-205.
Score: 0.171
-
A Systematic Review and Meta-Analysis of Clinical Outcomes of Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2022 11; 34(11):E763-E775.
Score: 0.166
-
Outcomes with retrograde versus antegrade chronic total occlusion revascularization. Catheter Cardiovasc Interv. 2020 11; 96(5):1037-1043.
Score: 0.136
-
Impact of Successful Chronic Total Occlusion Percutaneous Coronary Interventions on Subsequent Clinical Outcomes. J Invasive Cardiol. 2020 Nov; 32(11):433-439.
Score: 0.035
-
Meta-Analysis Comparing Percutaneous to Surgical Access in Trans-Femoral Transcatheter Aortic Valve Implantation. Am J Cardiol. 2020 04 15; 125(8):1239-1248.
Score: 0.034